Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InnovAge Holding (INNV) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for InnovAge Holding (INNV) over the last 6 years, with Q2 2025 value amounting to -$8.0 million.

  • InnovAge Holding's Asset Writedowns and Impairment fell 55341.3% to -$8.0 million in Q2 2025 from the same period last year, while for Dec 2025 it was -$8.0 million, marking a year-over-year decrease of 17712.63%. This contributed to the annual value of $524000.0 for FY2025, which is 9252.5% down from last year.
  • InnovAge Holding's Asset Writedowns and Impairment amounted to -$8.0 million in Q2 2025, which was down 55341.3% from $8.5 million recorded in Q4 2024.
  • InnovAge Holding's Asset Writedowns and Impairment's 5-year high stood at $8.5 million during Q4 2024, with a 5-year trough of -$8.0 million in Q2 2025.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $1.3 million (2022), whereas its average is $1.3 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first soared by 9577.34% in 2021, then plummeted by 55341.3% in 2025.
  • Quarter analysis of 5 years shows InnovAge Holding's Asset Writedowns and Impairment stood at $1.6 million in 2021, then tumbled by 58.33% to $673000.0 in 2022, then soared by 60.03% to $1.1 million in 2023, then skyrocketed by 688.77% to $8.5 million in 2024, then plummeted by 193.83% to -$8.0 million in 2025.
  • Its Asset Writedowns and Impairment was -$8.0 million in Q2 2025, compared to $8.5 million in Q4 2024 and $82000.0 in Q3 2024.